1. Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors
   Ali Saber et al, 2016, Carcinogenesis CrossRef
2. Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer
   Marcin Nicoś et al, 2022, Cancers CrossRef
3. Primary versus acquired epidermal growth factor receptor Thr790Met mutant non-small cell lung cancer: clinical features and prognoses
   Siqi Zhou et al, 2024, Clinical and Translational Oncology CrossRef
4. Coexistence of sensitive and resistant epidermal growth factor receptor (EGFR) mutations in pretreatment non-small cell lung cancer (NSCLC) patients: First or third generation tyrosine kinase inhibitors (TKIs)?
   Bo Zhang et al, 2018, Lung Cancer CrossRef
5. Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations
   Katsuhiro Masago et al, 2015, BMC Cancer CrossRef
6. Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer
   Xuefei Li et al, 2017, Oncotarget CrossRef
7. COLD-PCR Technologies in the Area of Personalized Medicine: Methodology and Applications
   Florence Mauger et al, 2017, Molecular Diagnosis & Therapy CrossRef
8. Roles of circRNAs in cancer chemoresistance (Review)
   Chuan Xin et al, 2021, Oncology Reports CrossRef
9. The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study
   Ping-Chih Hsu et al, 2020, Pharmaceuticals CrossRef
10. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
    Ping-Chih Hsu et al, 2019, International Journal of Molecular Sciences CrossRef
11. Reducing Artifactual EGFR T790M Mutations in DNA from Formalin-Fixed Paraffin-Embedded Tissue by Use of Thymine-DNA Glycosylase
    Hongdo Do et al, 2017, Clinical Chemistry CrossRef
12. Different characteristics and survival in non‐small cell lung cancer patients with primary and acquired EGFR T790M mutation
    Shuyuan Wang et al, 2019, International Journal of Cancer CrossRef
13. An endothelial growth factor receptor compound mutation of T790M substitution with exon 19 deletion in a previously untreated patient: a case report
    Juan C. Falla-Martinez et al, 2019, Journal of Medical Case Reports CrossRef
14. Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
    Li-Yang Chen et al, 2016, Lung Cancer CrossRef
15. Different Clinicopathologic and Computed Tomography Imaging Characteristics of Primary and Acquired EGFR T790M Mutations in Patients with Non-Small-Cell Lung Cancer
    Donghui Hou et al, 2021, Cancer Management and Research CrossRef
16. The use of COLD-PCR and pyrosequencing for sensitive detection of EGFR T790M mutation
    Huimin Chen et al, 2021, E3S Web of Conferences CrossRef